-The Hindu The Modi government’s policy is choking domestic demand at a time when global demand is also weak. This is hardly a recipe for double-digit growth. The title seems provocative. After all, for the last several months, we have all heard that India is now the fastest growing large economy in the world. The Finance Minister keeps assuring us that the country’s economic revival is on a firm footing and that...
More »SEARCH RESULT
Total Matching Records found : 677
India Inc needs more time to spend meaningfully -Radhika Merwin
-The Hindu Business Line Indian corporates are just settling in to the regime of mandatory spends on CSR activities. The Centre has so far been lenient and has allowed them to spend less than the required amount as long as they disclose the reason. Many companies, which have fallen short, have listed a variety of reasons for this short-fall. This varies from the need for more time to identifying the right CSR...
More »Lancet study puts India as the worst performing among BRICS nations on health indicators -Aradhna Wal
-DNA Despite a certain amount of progress in the past decade or so, the report points out glaring gaps in healthcare infrastructure in the country -- "low resource allocation, low emphasis on primary health care, poor utilisation of human resources," as Professor K Srinath Reddy, one of the co-authors said. Yet another report on India's troubled health care system pointed out the country's poor performance across health indicators, despite economic advantages....
More »Health scheme beneficiaries pay from own pockets -Mihika Basu
-The Indian Express TISS report maps pitfalls in Rajiv Gandhi Jeevandayee Arogya Yojana Mumbai: OVER three-fifths or 63 per cent beneficiaries of the state government’s Rajiv Gandhi Jeevandayee Arogya Yojana (RGJAY) made out-of-pocket (OOP) payments for services after admission to hospitals, and a significantly higher proportion of patients from Below Poverty Line (BPL) families (88.23 per cent) reported paying for diagnostics, medications, or consumables, according to a report by the Tata...
More »Cancer drugs, stents at 60% discount soon -Sushmi Dey
-The Times of India NEW DELHI: Over 200 cancer drugs, 186 medicines to treat cardiovascular diseases and 148 stents and cardiac implants will now be available at central government hospitals at prices 50-60% lower than the open market. The health ministry has launched a programme called AMRIT (Affordable Medicines and Reliable Implants for Treatment), under which the government will run pharmacy retail stores to sell medicines in hospitals like All India Institute...
More »
